Home » GENAERA RECEIVES PATENT FOR GENE VARIANTS OF INTERLEUKIN-9 RECEPTOR
GENAERA RECEIVES PATENT FOR GENE VARIANTS OF INTERLEUKIN-9 RECEPTOR
Genaera Corporation today announced issuance by the United States Patent and Trademark Office of patent number 7,056,698 entitled "Nucleic Acids Encoding Interleukin-9 Receptor Variants."
Drug Newswire (http://www.euro2day.gr/articlesfna/16501875/)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May